Mechanisms of ERK activation in gammaherpesvirus

伽马疱疹病毒中 ERK 激活机制

基本信息

  • 批准号:
    7678688
  • 负责人:
  • 金额:
    $ 2.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of three human malignancies, including Kaposi's sarcoma (KS), the most common AIDS-related neoplasm worldwide. While the widespread use of HAART therapy has resulted in a decline in the number of KS cases in the US, KS incidence has increased in developing countries where the AIDS epidemic continues. The long-term objective of this study is to broaden our understanding of the basic biology of gammaherpesviruses, including structure, assembly, and virus-host cell interactions. With the recent finding of ERK1/2 within the purified virion of Rhesus monkey rhadinovirus (RRV), a close homolog of KSHV, we began to speculate the importance of this pathway in viral infection. We hypothesize that the incorporation of these enzymes may represent a snapshot of the cellular environment during viral infection, reflecting a cellular pathway that is highly active in the vicinity of viral replication and assembly and that may play important roles during virus production. Two specific aims are proposed to test this hypothesis. The first is designed to determine the structural aspect of ERK1/2 incorporation. We will biochemically confirm mass spectrometry data, while also determining structural localization, species-specificity, and approximate abundance of these species within the particle. The second is to define the interaction between RRV and the MEK/ERK pathway during de novo infection. We will determine the kinetics of ERK activation, as well as define a mechanism for late phase activation. With the use of viral DNA replication inhibitors, as well as global transcription and translation inhibitors, we will assess role of potential viral gene (s) and cellular processes in activating ERK during RRV infection. Relevance to public health: Viruses, having evolved with the host, have found ways to manipulate the cellular environment for their benefit. This project is designed to provide insight into how gammaherpesviruses interact with and use the MEK/ERK pathway during viral infection. Due to the weakened immune system of AIDS patients, KS treatment is often limited; however, our studies may identify virus and cancer cell specific markers that may become targeted therapies for KS. This approach may enable us to interfere with infection and subsequent disease progression, even in the absence of a healthy immune system.
描述(由申请人提供):卡波西肉瘤相关疱疹病毒(KSHV)是三种人类恶性肿瘤的病原体,包括卡波西肉瘤(KS),这是全球最常见的艾滋病相关肿瘤。虽然HAART疗法的广泛使用导致美国KS病例数下降,但在艾滋病流行持续的发展中国家,KS发病率却有所增加。这项研究的长期目标是扩大我们对γ疱疹病毒的基本生物学的理解,包括结构,组装和病毒-宿主细胞相互作用。随着最近在恒河猴Rhadinovirus(RRV)的纯化病毒粒子中发现ERK 1/2,我们开始推测该途径在病毒感染中的重要性。我们假设这些酶的掺入可能代表病毒感染期间细胞环境的快照,反映了在病毒复制和组装附近高度活跃的细胞途径,并且可能在病毒产生期间发挥重要作用。提出了两个具体目标来检验这一假设。第一个目的是确定ERK 1/2掺入的结构方面。我们将生化确认质谱数据,同时还确定结构定位,物种特异性和这些物种在颗粒内的近似丰度。第二个是定义在从头感染期间RRV和MEK/ERK通路之间的相互作用。我们将确定ERK激活的动力学,以及定义晚期激活的机制。通过使用病毒DNA复制抑制剂以及全局转录和翻译抑制剂,我们将评估潜在病毒基因和细胞过程在RRV感染期间激活ERK中的作用。与公共卫生的相关性:病毒随着宿主的进化,已经找到了操纵细胞环境的方法。该项目旨在深入了解γ疱疹病毒在病毒感染期间如何与MEK/ERK通路相互作用并使用MEK/ERK通路。由于艾滋病患者的免疫系统较弱,KS治疗往往是有限的;然而,我们的研究可能会发现病毒和癌细胞特异性标记物,可能成为KS的靶向治疗。这种方法可能使我们能够干扰感染和随后的疾病进展,即使在没有健康的免疫系统的情况下。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Evonne N Woodson其他文献

Evonne N Woodson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Evonne N Woodson', 18)}}的其他基金

Mechanisms of ERK activation in gammaherpesvirus
伽马疱疹病毒中 ERK 激活机制
  • 批准号:
    8119142
  • 财政年份:
    2009
  • 资助金额:
    $ 2.79万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 2.79万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 2.79万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 2.79万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 2.79万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 2.79万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 2.79万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 2.79万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 2.79万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 2.79万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 2.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了